Bioglan e.g.m. backs purchase

Shareholders in Bioglan Pharma have approved the acquisition of a range of dermatological products from Medicis Pharmaceutical…

Shareholders in Bioglan Pharma have approved the acquisition of a range of dermatological products from Medicis Pharmaceutical Corp. At an e.g.m. yesterday, they also approved a placing and open offer to finance the acquisition. The results of the offer will be announced on July 21st.

  • Join The Irish Times on WhatsApp and stay up to date

  • Sign up to the Business Today newsletter for the latest new and commentary in your inbox

  • Listen to Inside Business podcast for a look at business and economics from an Irish perspective